Загрузка...
ACTR-26. TOXICITY AND EFFICACY OF LOMUSTINE PLUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS
BACKGROUND: Bevacizumab combined with chemotherapy has shown high response rates in recurrent glioblastoma patients and responding patients have improved survival and quality of life. The Danish treatment recommendations for recurrent glioblastoma patients were recently changed by replacing irinotec...
Сохранить в:
| Опубликовано в: : | Neuro Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692348/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.021 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|